RE: Medusa 19 “Affiliated to The National Microbiology Framework”8 Sep 2021 11:08
Bella, Not entirely sure but there was significant investment last year.
A North West COVID-19 testing operation has invested £20m to ramp up production.
Testing and diagnostics company Medusa 19 is increasing production of a 10-minute Rapid Saliva Protein Test (RSPT) that indicates immune response to COVID-19.
Established by Richard Hughes, founder of Zeus Capital, and Mahmud Kamani, both founder shareholders of Boohoo.com, the significant investment has enabled production of 2.5m tests, retailing at £29.99 per test, ready to be distributed to UK and international companies.
With many businesses looking to implement affordable organisation-wide testing to monitor viral outbreaks and ensure the workplace is safe for employees to remain in, Medusa 19 is planning to ramp up production to 50 million tests each month at its manufacturing site in the Wirral.